I don't like pubs <a href=" http://1disease.org/doxycycline-cheap.pdf#testing ">cheapest form of doxycycline</a> I was wondering if you could talk about what additional cost areas you're likely to attack next. And how much of the $20 million to $25 million in operating losses in '13 from new initiatives are still ahead of us?